Get started
Clover Health Investments, Corp.Clover Health Investments, Corp.Clover Health Investments, Corp.

Clover Health Investments, Corp.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

CLOV trade ideas

CLOV - Potential escalating AI driven healthcare companyClover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings. Clover Health (NASDAQ:CLOV) is a healthcare company that provides Medicare Advantage insurance plans and operates as a direct contracting entity of the US government. Yahoo Finance! reports three analysts covering the stock with one buy rating and two hold ratings for July 2024. CLOV reported very strong financials for Q2 2024. While revenue grew by 7%, the net profit margin grew by 75.33%. Moreover, this quarter marks the first quarter of positive net income for the company. As a result of such good earnings, management has improved full-year guidance. The level of improvement is best seen through EBITDA projections. Originally, EBITDA guidance was between a $20 million loss and gain; now, it is between $50 and $65 million. The company has developed Clover Assistant, an AI assistant SaaS. The assistant is meant to serve as a clinical decision-making tool for payers and providers based on the patient’s medical and financial data. Furthermore, the assistant tool allows CLOV to expand in areas that Medicare Advantage doesn’t reach. It also has the potential for one-on-one use with Medicare Advantage patients as a recurring revenue stream on a use-by-use basis. Developments with AI and an improving financial outlook make CLOV one of the healthcare stocks for investors to consider. Recent Insider Buy of 531,700 shares worth over 1M AI driven healthcare insurance platform We've recently witnessed a significant overextended breakout, and there's potential for a pullback to the 2.20-2.30 zone, which could present an ideal entry point. If this pullback occurs, and we observe insiders increasing their share purchases at these levels again, it would strongly reinforce the validity of this entry strategy. Breakout Zone: $3.50 - 3.80 Action: If the stock breaks above this area with strong volume, it might signal a continuation of the upward trend. Overall Market Sentiment: Currently, the market seems to be in a correction phase. It’s crucial to consider this sentiment when making trading decisions. Resistance Points: $3.50 $3.80 $4.40 $5.20 Surpassing these levels could signal a positive trend. Consider taking profits at these stages to realize gains. Trading Strategy: Take Profit (TP): Set a target at $6.50 (This could be just the beginning of an extraordinary journey ahead.) Stop Loss (SL): Set at under $1.90 to mitigate potential losses. Chart Analysis: Please refer to the attached chart for detailed analysis of price trends and movements. Trading Advisory: Exercise caution and consider market conditions and your own risk tolerance when trading. It's advisable to conduct comprehensive research or consult with a financial advisor before engaging in trading activities. Disclaimer: This content is for informational purposes only and should not be considered financial advice.
NASDAQ:CLOVLong
by meitshels_smell_trades
13
Clover Health StudyClover Health Study shows a potential upside gain based on the Fibonacci principals that look to keep reasonable positive success for entry and exit levels. So if you are even 66% correct - you will win 66% - but unless you do not have time - HOLD & Wait, as you will win. Every time you Sell You Destroy your Capital. Use Stop Losses to preserve your Capital. Do not rush into an Investment - watch and observe. Do not Day Trade. Day traders cannot see the long term trend and often loose in my opinion. Also timing the low entry points on an investment is even difficult for the professionals - so forget getting that right. Slow but Dollar Averaging does work when you study the market and trends you will win. Keep learning and Invested. Regards Graham. Thoughts - Studies - Idea's are welcome.
NASDAQ:CLOVLong
by hitchcoxg
2
CLOV - Accumulation 🤔20% move today and CLOV has leaped back above the 2.618 long term fib taken way back in September. So much fakery in this chart and more than I have time for but have a look at that bearish rejection star through 2.618 yesterday. And so CLOV probes above the 50WMA for the first time since October. And if you look at wyckoff schematics CLOV could now be at SOS. This has been reached via an ABC 1:1 which I think will probably top in this area although could go further to 1.618. If it does top and retrace to a bullish 0.382 then it would consolidate on the 2.618 long term fib and that could be BU/LPS. Its a difficult one to call now because SPX is cliff walking and the black swan is having a war - these are uncertain times and uncertainty is bad for equities. If SPX does have a big bounce then there is a good chance CLOV will pump hard, however there will be lots of names with better RR to choose from when SPX finally corrects, and thats what I'm really waiting for. And if SPX collapses in this area you can be sure that this potential accumulation - looking very cute straight out a textbook, will become an X wave to see CLOV hit $0.5. A "safer" way to play this would perhaps be to wait for an established trend to enter. Not advice.
NASDAQ:CLOV
by dRends35
12